Ewing's Sarcoma with Non-Sacral Pelvic Primary Tumour Localisation: Clinical Management

Clinical Scenario

This protocol addresses Ewing's sarcoma originating from a non-sacral pelvic primary site — a presentation with distinct local control challenges arising from tumour location, proximity to critical structures, and the complexity of achieving adequate surgical clearance.

Non-Sacral Pelvic Localisation

Pelvic primary localisation is a recognised factor shaping local therapy decisions in Ewing's sarcoma. Adjuvant radiotherapy is recommended in patients with non-sacral pelvic disease regardless of surgical margins, tumour volume, or histological response — a recommendation supported by evidence of superior local control and overall survival outcomes compared with surgery alone.

Treatment Approach (Partial Overview)

Management follows a multimodal strategy beginning with neoadjuvant induction chemotherapy, proceeding through local therapy and consolidation — the complete regimen, sequencing, and site-specific radiotherapy protocol are detailed in the full structured document.

Treatment Goals

Key indicators of response include complete histological tumour response on surgical specimen assessment, and reduction in the size of the soft tissue mass on MRI.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.annonc.2021.08.1995

The interval-compressed VDC/IE regimen showed superiority to VIDE for both event-free survival and OS, with similar toxicity, and it is currently the preferred first-line treatment in ES [I, B].
Generally, up to nine cycles of induction ChT is delivered after biopsy, followed by local therapy, and consolidation thereafter.
Overall treatment duration is 10-12 months.
Complete surgical excision, where feasible, is regarded as the best modality of local control, given the higher risk of LR when RT is used as the sole treatment [IV, A].
Also, adjuvant RT should be considered in patients with non-sacral pelvic ES regardless of surgical margins, tumour volume or histological response, as this was shown to have superior local control and survival outcomes compared with surgery alone [II, B].

View source ↗